MARK OLDAKOWSKI - 11 Sep 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Chief Operating Officer
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
11 Sep 2025
Transactions value $
-$240
Form type
4
Filing time
12 Sep 2025, 16:49:30 UTC
Previous filing
03 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
OLDAKOWSKI MARK Chief Operating Officer C/O BIONANO GENOMICS, INC., 9540 TOWNE CENTRE DRIVE, SUITE 100, SAN DIEGO /s/ Jonathan V. Dixon, Attorney-in-Fact 12 Sep 2024 0001745566
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNGO Common Stock Tax liability -$240 -59 -6.06% $4.06 915 11 Sep 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is reporting the withholding by the Issuer an aggregate of 59 shares of common stock that vested on September 11, 2025, pursuant to an RSU award granted on September 11, 2023, but that were not issued in order to satisfy the reporting person's tax withholding obligations upon settlement of the RSU award.